TORONTO, June 03, 2021 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) (“Field Trip”), a leader in the development and delivery of psychedelic therapies, is pleased to announce that its common shares will commence trading on the Toronto Stock Exchange (“TSX”) under the ticker symbol “FTRP” and its warrants will trade under the symbol “FTRP.WT” at the opening of the…

Source

Previous articleMindset Selects its Lead Clinical Candidate, MSP-1014, a Next Generation Psychedelic Medicine
Next articleMINDCURE Successfully Completes First Stage of Manufacturing Synthetic Ibogaine for Use in Psychedelic Clinical Research